Author pages are created from data sourced from our academic publisher partnerships and public sources.
Share This Author
Guidelines on management (diagnosis and treatment) of syncope.
Table of contents Preamble Scope of the document 1256 Method 1257 Part 1. Classification, epidemiology and prognosis Definition 1258 Brief overview of pathophysiology of syncope 1258 Classification… Expand
Guidelines on management (diagnosis and treatment) of syncope--update 2004.
- M. Brignole, P. Alboni, +17 authors W. Wieling
- Europace : European pacing, arrhythmias, and…
- 1 November 2004
Executive Summary ESC Committee for Practice Guidelines (CPG): Silvia G. Priori (Chairperson) (Italy), Maria Angeles Alonso Garcia (Spain), Jean-Jacques Blanc (France), Andrzej Budaj (Poland),… Expand
Task force on syncope, European Society of Cardiology. Part 2. Diagnostic tests and treatment: summary of recommendations.
2018 ESC Guidelines for the diagnosis and management of syncope
Authors/Task Force Members: Michele Brignole* (Chairperson) (Italy), Angel Moya* (Co-chairperson) (Spain), Frederik J. de Lange (The Netherlands), Jean-Claude Deharo (France), Perry M. Elliott (UK),… Expand
Practical Instructions for the 2018 ESC Guidelines for the diagnosis and management of syncope
The content of these European Society of Cardiology (ESC) Guidelines has been published for personal and educational use only. No commercial use is authorized. No part of the ESC Guidelines may be… Expand
Task force on syncope, European Society of Cardiology. Part 1. The initial evaluation of patients with syncope.
Safe and effective conversion of persistent atrial fibrillation to sinus rhythm by intravenous AZD7009.
BACKGROUND Acute drug conversion of persistent atrial fibrillation usually fails. OBJECTIVES The purpose of this study was to test the proarrhythmic potential, safety, and efficacy of the novel… Expand
Rapid Conversion of Persistent Atrial Fibrillation to Sinus Rhythm by Intravenous AZD7009
This randomized, double‐blind trial compared cardioversion rates between AZD7009 infusion (15‐minute 3.25 mg/min, 15‐minute 4.4 mg/min, or 30‐minute 3.25 mg/min) and placebo infusion (15 or 30… Expand
Antazoline for rapid termination of atrial fibrillation during ablation of accessory pathways.
- R. Piotrowski, T. Kryński, J. Baran, P. Futyma, S. Stec, P. Kułakowski
- Cardiology journal
BACKGROUND AND AIM To assess safety and efficacy of antazoline for termination of atrial fibrillation (AF) occurring during ablation of accessory pathways (AP). METHODS We analyzed… Expand
Exercise producing alterations in the signal-averaged electrocardiogram in patients after myocardial infarction.
Late potentials are considered to be a marker for regional slow conduction which might predispose to reentrant ventricular arrhythmias. Since these arrhythmias may be induced by ischaemia it may be… Expand